Tawata M, Yoda Y, Aida K, Shindo H, Sasaki H, Chin M, Onaya T
Third Department of Internal Medicine, University of Yamanashi Medical School, Japan.
Planta Med. 1990 Jun;56(3):259-63. doi: 10.1055/s-2006-960951.
We have purified GU-7, a 3-arylcoumarin derivative, from glycyrrhizae radix, which is a crude drug of kampo herbal medicines. This was identified to be a new chemical compound and was found to have an anti-platelet action. GU-7 inhibited platelet aggregation, phosphorylation of 40K and 20K dalton proteins, inositol 1,4,5-trisphosphate production, intraplatelet calcium increase and phosphodiesterase activity in vitro. The data indicate that GU-7 inhibits platelet aggregation by increasing intraplatelet cAMP concentration. We have already reported the existence of aldose reductase inhibitors in some kampo medicines. In addition to the aldose reductase inhibiting action, anti-platelet action may also explain the mechanism by which kampo medicines are effective to diabetic neuropathy.
我们从甘草(汉方药的一种生药)中提纯出了3-芳基香豆素衍生物GU-7。它被鉴定为一种新的化合物,并被发现具有抗血小板作用。GU-7在体外可抑制血小板聚集、40K和20K道尔顿蛋白的磷酸化、肌醇1,4,5-三磷酸的产生、血小板内钙增加以及磷酸二酯酶活性。数据表明,GU-7通过增加血小板内cAMP浓度来抑制血小板聚集。我们已经报道了一些汉方药中存在醛糖还原酶抑制剂。除醛糖还原酶抑制作用外,抗血小板作用也可能解释汉方药对糖尿病神经病变有效的机制。